Minor swelling or redness may occur and typically resolves within a few hours
Theres been a lot of hype about GLP-1 peptides over the past few years due to their measurable success at helping people lose significant weight and reduce the biomarkers related to type-2 diabetes
The changes in HDL-C, triglycerides, and total cholesterol were similar in STEP-1 and SELECT, and there remained a significant decrease in LDL-C even though patients started at a lower LDL-C level [33, 48]
Some companies are only looking to make the semaglutide peptide, which is the active ingredient, but more established players are planning to manufacture as well as market the drug. Among the companies planning to tap into the Indian market next year is Lupin, a well-known Indian generic-drug maker
Hormonal shifts Semaglutide impacts hormones like insulin and glucagon, which regulate blood sugar levels
Hakami* 49